Fortrea Holdings (FTRE) Common Equity (2022 - 2026)

Fortrea Holdings (FTRE) reported Common Equity of $525.9 million for Q1 2026, down 38.76% on a YoY basis from $858.8 million in Q1 2025, and down 6.67% quarter-over-quarter from $563.5 million in Q4 2025.

Fortrea Holdings (FTRE) Common Equity (2022 - 2026) Analysis & Trends

Fortrea Holdings has reported Common Equity for 5 years, with the latest figure at $525.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Common Equity fell 38.76% year-over-year to $525.9 million; the trailing twelve-month figure through Mar 2026 stood at $525.9 million (down 38.76% YoY), and the FY2025 full-year result was $563.5 million, down 58.64% from the prior year.
  • Common Equity for Q1 2026 stood at $525.9 million, down from $563.5 million in the prior quarter.
  • The five-year high for Common Equity was $3.4 billion in Q1 2023, with the low at $525.9 million in Q1 2026.
  • Historically, Common Equity has averaged $1.6 billion across 5 years, with a median of $1.5 billion in 2024.
  • Annual changes were most pronounced in 2024 — Common Equity declined 10.47% — and 2025, when it sank 61.63%.
  • Fortrea Holdings' Common Equity stood at $3.3 billion in 2022, then sank by 48.68% to $1.7 billion in 2023, then decreased by 20.52% to $1.4 billion in 2024, then sank by 58.64% to $563.5 million in 2025, then slipped by 6.67% to $525.9 million in 2026.
  • The last three Common Equity figures came in at $525.9 million (Q1 2026), $563.5 million (Q4 2025), and $580.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 35.63 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -1.42 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 13.21 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 11.87 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn 525.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 525.90 Mn
Dec 31, 2025 563.50 Mn
Sep 30, 2025 580.80 Mn
Jun 30, 2025 589.20 Mn
Mar 31, 2025 858.80 Mn
Dec 31, 2024 1.36 Bn
Sep 30, 2024 1.51 Bn
Jun 30, 2024 1.46 Bn
Mar 31, 2024 1.59 Bn
Dec 31, 2023 1.71 Bn
Sep 30, 2023 1.69 Bn
Jun 30, 2023 1.75 Bn
Mar 31, 2023 3.40 Bn
Dec 31, 2022 3.34 Bn
Jun 30, 2022 3.30 Bn